Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Varian Software Successfully Connected with Siemens Linear Accelerators

13.06.2013
- Clinicians are now using Varian software to manage patient treatments on a Siemens Oncor medical linear accelerator

- FDA clearance for connectivity between Varian's ARIA oncology information system and Siemens' Linacs Oncor and Primus

Varian Medical Systems and Siemens Healthcare today announced that clinicians at The Ohio State University (Ohio State), USA, are now using Varian software to plan and manage radiotherapy treatments delivered on a Siemens medical linear accelerator.



The companies have developed and deployed an interface that connects Varian's ARIA oncology information system with Siemens' Oncor and Primus accelerators and imaging systems. This step – as part of the company's "Agenda 2013" sector initiative – demonstrates once again Siemens Healthcare's role as a strong partner for imaging systems in radiation oncology.

Clinicians at The Ohio State University, USA, are now using Varian software to plan and manage radiotherapy treatments delivered on a Siemens medical linear accelerator. Varian Medical Systems and Siemens Healthcare have developed and deployed an interface that connects Varian's ARIA oncology information system with Siemens' Oncor and Primus accelerators and imaging systems.

"Since we launched the global strategic partnership with Siemens last year, we have been steadily working to develop software interfaces that enable clinics with Siemens linear accelerators to manage patient care using Varian software," says Kolleen Kennedy, president of Varian's Oncology Systems business. "With this new interface, we can connect to about 80 percent of the Siemens equipment in the field. Now the majority of Siemens-equipped sites can choose to adopt ARIA for managing all aspects of care, from initial diagnosis through post-treatment follow-up."

In March of this year, Siemens received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for connectivity between Varian's ARIA software and Siemens' Oncor and Primus linear accelerators.

"Developing these interfaces was one of our main goals when we launched our partnership last year," says Walter Märzendorfer, CEO of Siemens Computed Tomography and Radiation Oncology. "We're pleased to have now released this interface and completed the first deployment at such a luminary U.S. treatment center. We would like to thank the team at The Ohio State University for valuable clinical input during the interface development process, and for helping our teams identify ways of enhancing the workflow when Varian software is used to manage treatment on a Siemens linear accelerator."

The deployment at Ohio State marks an important milestone in the two companies' cooperation. "This demonstrates our commitment to the community of Siemens technology users," Kennedy says. "It allows us to offer them a seamlessly integrated option for improving workflow and streamlining operations."

Varian has also launched a special service and support program to support oncology treatment centers converting to ARIA from other third-party oncology information systems, including the Lantis system from Siemens. The program is designed to provide data conversion, workflow consulting and application training, as well as software connectivity licenses.

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2012 (to September 30), the Sector posted revenue of 13.6 billion euros and profit of 1.8 billion euros. For further information please visit: http://www.siemens.com/healthcare

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes, digital detectors, and image processing workstations for X-ray imaging in medical, scientific, and industrial applications and also supplies high-energy X-ray devices for cargo screening and non-destructive testing applications. Varian Medical Systems employs approximately 6,200 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com.

Launched in November 2011, Agenda 2013 is an initiative of the Siemens Healthcare Sector to further strengthen its innovative power and competitiveness. Specific measures, which will be implemented by the end of 2013, have been defined in four fields of action: innovation, competitiveness, regional footprint, and people development.

The products/features (here mentioned) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Further details are available from the local Siemens organizations.

Reference Number: HIM201306019e

Contact
Mr. Ulrich Künzel
Healthcare Sector
Siemens AG
Henkestr. 127
91052 Erlangen
Germany
Tel: +49 (9131) 84-3473
Ulrich.Kuenzel@siemens.com
Ms. Meryl Ginsberg
Siemens AG
Tel: +1 (650) 424-6444
Meryl.Ginsberg@varian.com

Ulrich Künzel | Siemens Healthcare
Further information:
http://www.siemens.com/healthcare
http://www.varian.com

More articles from Medical Engineering:

nachricht A first look at interstitial fluid flow in the brain
05.07.2018 | American Institute of Physics

nachricht A sentinel to watch over ocular pressure
04.07.2018 | Fraunhofer Institute for Microelectronic Circuits and Systems

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

Im Focus: Chemical reactions in the light of ultrashort X-ray pulses from free-electron lasers

Ultra-short, high-intensity X-ray flashes open the door to the foundations of chemical reactions. Free-electron lasers generate these kinds of pulses, but there is a catch: the pulses vary in duration and energy. An international research team has now presented a solution: Using a ring of 16 detectors and a circularly polarized laser beam, they can determine both factors with attosecond accuracy.

Free-electron lasers (FELs) generate extremely short and intense X-ray flashes. Researchers can use these flashes to resolve structures with diameters on the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

NYSCF researchers develop novel bioengineering technique for personalized bone grafts

18.07.2018 | Life Sciences

Machine-learning predicted a superhard and high-energy-density tungsten nitride

18.07.2018 | Materials Sciences

Why might reading make myopic?

18.07.2018 | Health and Medicine

VideoLinks
Science & Research
Overview of more VideoLinks >>>